China human vaccine market hit $1.59 billion in 2010

With the improvement of economy and people's disease prevention awareness, China's human vaccine market has expanded in recent years, growing at a compound annual growth rate (CAGR) of 24.0% in 2007-2010. In particular, the market scale in 2010 hit 10.3 billion renminbi ($1.59 billion), up 14.4% year-on-year.

Under the influence of China's actual conditions and the vaccine industry characteristics, state-owned human vaccine enterprises take a lion's share in the market, especially in the EPI (Expanded Program on Immunization) vaccines market. In terms of lot release quantity, state-owned enterprises occupied 68.1% of the extra EPI vaccines market in 2010. According to a new report, titled China Human Vaccine Industry 2010-2011, added to the offering of Research and Markets.